SCHEMBL27852998

SCHEMBL27852998

CC(C)(C)C(=O)ON1CCC(=O)CC1Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.39
▸ NR1H2 P55055 2/20 0.36
▸ NR1H3 Q13133 2/20 0.36
▸ DAGLA Q9Y4D2 1/20 0.35
▸ PLA2G10 O15496 1/20 0.35
▸ PLA2G5 P39877 1/20 0.35
▸ KLK7 P49862 1/20 0.35
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ PSEN1 P49768 1/20 0.34
▸ PSEN2 P49810 1/20 0.34
▸ APH1B Q8WW43 1/20 0.34
▸ NCSTN Q92542 1/20 0.34
▸ APH1A Q96BI3 1/20 0.34
▸ PSENEN Q9NZ42 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27965685 0.88 TSHR (0.36) CYP3A4CYP2C9CYP2C19
SCHEMBL9425606 0.84 ABCB1 (0.39) ABCB1CYP3A4CYP2C9CYP2C19
SCHEMBL9425643 0.84 ABCB1 (0.39) ABCB1CYP3A4CYP2C9CYP2C19
SCHEMBL9425388 0.84 ABCB1 (0.39) ABCB1CYP3A4CYP2C9CYP2C19
SCHEMBL27767276 0.80 — —
SCHEMBL27914285 0.79 CA1 (0.49) ABCB1NR1H2NR1H3
SCHEMBL28064896 0.79 RIPK1 (0.48) L3MBTL1
SCHEMBL27767322 0.78 ABCB1 (0.39) ABCB1NR1H2NR1H3PLA2G10PLA2G5
SCHEMBL27510237 0.77 CA1 (0.49) —
SCHEMBL27853009 0.77 MME (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102459246-B Isoxazol-3 (2H) -one analogs as therapeutic agents ASTRAZENECA AB 2014-05-07 — — CN disclosed
CN-102459246-A Isoxazol-3 (2H) -one analogs as therapeutic agents ASTRAZENECA AB 2012-05-16 — — CN disclosed
Send feedback